Miguel Xavier
Fernandes
Researcher in the period 2013-2022
Universidad de Sevilla
Sevilla, EspañaPublications in collaboration with researchers from Universidad de Sevilla (9)
2024
-
Coumarin-azasugar-benzyl conjugates as non-neurotoxic dual inhibitors of butyrylcholinesterase and cancer cell growth
Organic & biomolecular chemistry, Vol. 22, Núm. 17, pp. 3425-3438
2023
-
Conformationally Restricted Glycoconjugates Derived from Arylsulfonamides and Coumarins: New Families of Tumour-Associated Carbonic Anhydrase Inhibitors
International Journal of Molecular Sciences, Vol. 24, Núm. 11
-
Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 38, Núm. 1, pp. 349-360
2022
-
2-Aminobenzoxazole-appended coumarins as potent and selective inhibitors of tumour-associated carbonic anhydrases
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 37, Núm. 1, pp. 168-177
-
A hybrid of 1-deoxynojirimycin and benzotriazole induces preferential inhibition of butyrylcholinesterase (BuChE) over acetylcholinesterase (AChE)
Journal of enzyme inhibition and medicinal chemistry, Vol. 37, Núm. 1, pp. 2395-2402
-
Carbohydrate-derived bicyclic selenazolines as new dual inhibitors (cholinesterases/OGA) against Alzheimer's disease
Bioorganic Chemistry, Vol. 127
-
Squaramide-Tethered Sulfonamides and Coumarins: Synthesis, Inhibition of Tumor-Associated CAs IX and XII and Docking Simulations
International Journal of Molecular Sciences, Vol. 23, Núm. 14
2021
-
Tuning the activity of iminosugars: novel N-alkylated deoxynojirimycin derivatives as strong BuChE inhibitors
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 36, Núm. 1, pp. 138-146
2019
-
Selenocoumarins as new multitarget antiproliferative agents: Synthesis, biological evaluation and in silico calculations
European Journal of Medicinal Chemistry, Vol. 179, pp. 493-501